Over the next 3 years, IDEXX Cancer Dx will expand to include most canine cancer cases IDEXX Laboratories shared earlier this month the launch of IDEXX Cancer Dx, a diagnostic panel with early ...

Clinical trial sites across nine states have closed for one of the largest canine lymphoma studies Effectiveness data will soon be finalized for statistical review and FDA submission LONG BEACH ...

"The completion of our critical study for LAVERDIA®-CA1 marks a major milestone in bringing forward an innovative therapy for canine lymphoma", said Dylan Balsz, CEO of Anivive. "We are excited ...

Cancer remains a leading cause of death in canines, with 1 in 4 dogs in the U.S. expected to be diagnosed with cancer in their lifetime. 2 Lymphoma, one of the most common cancers in dogs ...

Lymphoma is a type of cancer that affects the lymphatic system, and it can also involve the nervous system in both cats and dogs. This condition is particularly concerning because it can manifest ...

Feb. 14, 2025 /PRNewswire/ -- Anivive, a software-driven pet health company, today announced the successful completion of its pivotal field study evaluating the safety and effectiveness of ...

A Japanese man who went viral for mimicking a dog has launched a new business renting out his dog costume to like-minded people. As a result, he hopes those who share his interests, will be able ...

Primary Effusion Lymphoma (PEL) is a rare and aggressive form of B-cell lymphoma that typically manifests in body cavities, leading to the accumulation of fluid (effusions) without the presence of ...

IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced the launch of IDEXX Cancer Dx, a first-of-its-kind diagnostic panel with early detection of lymphoma in dogs, ...

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the drug closer to approval The field study for Laverdia-CA1’s (verdinexor ...